==Approvals and indications== Vandetanib was the first drug to be approved by FDA (April 2011) for treatment of late-stage (metastatic) medullary thyroid cancer in adult patients who are ineligible for surgery. Vandetanib was first initially marketed without a trade name, and is being marketed under the trade name Caprelsa since August 2011. ==Con...
Found on
http://en.wikipedia.org/wiki/Vandetanib
A substance being studied in the treatment of several types of cancer. It blocks the growth of new blood vessels that tumors need to grow. It also blocks enzymes needed for cell growth and may kill cancer cells. Vandetanib is a type of antiangiogenesis agent and a type of epidermal growth factor receptor inhibitor. Also called Zactima and ZD6474.
Found on
http://www.cancer.gov/dictionary?expand=V
No exact match found.
